Invention Grant
- Patent Title: Hepatitis B antiviral agents
-
Application No.: US16892373Application Date: 2020-06-04
-
Publication No.: US11760755B2Publication Date: 2023-09-19
- Inventor: Yao-Ling Qiu , Xiaowen Peng , Xuri Gao , Wei Li , Hui Cao , Byung-Chul Suh , Jorden Kass , Jiajun Zhang , Yat Sun Or
- Applicant: ENANTA PHARMACEUTICALS, INC.
- Applicant Address: US MA Watertown
- Assignee: Enanta Pharmaceuticals, Inc.
- Current Assignee: Enanta Pharmaceuticals, Inc.
- Current Assignee Address: US MA Watertown
- Agency: Elmore Patent Law Group, P.C.
- Agent Edgar W. Harlan; Carolyn S. Elmore
- Main IPC: C07D453/00
- IPC: C07D453/00 ; C07D487/04 ; C07D519/00 ; A61P31/20 ; A61K38/21 ; A61K31/5383 ; A61K45/06 ; A61K31/519
Abstract:
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, thereof:
which inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV life cycle of the hepatitis B virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HBV infection. The invention also relates to methods of treating an HBV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
which inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV life cycle of the hepatitis B virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HBV infection. The invention also relates to methods of treating an HBV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
Information query
